IBRX
IBRX
NASDAQ · Biotechnology

Immunitybio Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$7.32
+0.10 (+1.39%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,386.2% upside
Low Target $71.54
Average Target $108.79
High Target $142.95
Current Price $7.32
Current
$7.32
Target
$108.79
$71.54 $108.79 avg $142.95
Scenario Analysis
Bear Case
$71.54
877.3%
Low target
Base Case
$108.79
+1,386.2%
Avg target
Bull Case
$142.95
+1,852.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$12.43
-41.1% from high
52-Week Low
$1.95
+275.4% from low
50-Day SMA
$4.22
+73.5% vs SMA
200-Day SMA
$2.95
+148.1% vs SMA
RSI (14)
70.9
Overbought
Target vs 52W High
$108.79
+775.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%